Vaxneuvance Injection, Suspension
Product Images NDC 0006-4329

1 FDA label image from Merck Sharp & Dohme Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Vaxneuvance (NDC 0006-4329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Syringe Carton)

Principal Display Panel (0.5 mL Syringe Carton)
Packaging label for VAXNEUVANCE, Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed, suspension for intramuscular injection. The carton contains 10 single-dose 0.5 mL syringes. The label includes storage instructions to refrigerate and identifies Merck Sharp & Dohme LLC as the manufacturer with NDC 0006-4329-03.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.